The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

13 articles for LJ Pease


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
A novel series of histone deacetylase inhibitors incorporating hetero aromatic ring systems as connection units.EBI
Abbott Laboratories
Alpha-keto amides as inhibitors of histone deacetylase.EBI
Abbott Laboratories
Indole amide hydroxamic acids as potent inhibitors of histone deacetylases.EBI
Abbott Laboratories
Trifluoromethyl ketones as inhibitors of histone deacetylase.EBI
Abbott Laboratories
Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC).EBI
Abbott Laboratories
Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families.EBI
Abbott Laboratories
Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitors.EBI
Abbott Laboratories
7-Aminopyrazolo[1,5-a]pyrimidines as potent multitargeted receptor tyrosine kinase inhibitors.EBI
Abbott Laboratories
Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor.EBI
Abbott Laboratories
Thienopyridine urea inhibitors of KDR kinase.EBI
Abbott Laboratories
Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinases.EBI
Abbott Laboratories
Poly (ADP-ribose) polymerase inhibitorBDB
Chengdu Diao Pharmaceutical Group
Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease.BDB
Abbott Laboratories